FDA Approves Self-Collection cobas HPV Test for Early Detection of Cervical Cancer Early
In 2014, the cobas human papillomavirus test was approved by the FDA for first-line, primary screening in women aged 25 years and older.
Matt Sause National Institutes Of Health National Institutes Thinprep Preserv Solution Surepath Perservative High Grade Cervical
Source: pharmacytimes.com